ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
12.05
-0.20 (-1.63%)
At close: Jan 22, 2026, 4:00 PM EST
12.00
-0.05 (-0.41%)
After-hours: Jan 22, 2026, 7:04 PM EST
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $1.17 billion as of January 22, 2026. Its market cap has increased by 99.88% in one year.
Market Cap
1.17B
Enterprise Value
893.80M
1-Year Change
99.88%
Ranking
Category
Stock Price
$12.05
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has increased from $741.98M to $1.17B, an increase of 58.16%. That is a compound annual growth rate of 8.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 1.17B | 47.31% |
| Dec 31, 2025 | 796.64M | 39.89% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnaptysBio | 1.30B |
| Xeris Biopharma Holdings | 1.27B |
| Capricor Therapeutics | 1.26B |
| Inventiva | 1.23B |
| Pharming Group | 1.22B |
| Septerna | 1.19B |
| Aktis Oncology | 1.19B |
| Inhibrx Biosciences | 1.17B |